Implementation of a national nuchal translucency education and quality monitoring program

Obstetrics and Gynecology

Volumn 123, Issue 1, 2014, Pages 149-154

  D'Alton, Mary E ^{a,b,c,d,e,f,g,h}   Fuchs, Karin M ^{a,b,c,d,e,f,g,h}   Abuhammad, Alfred ^{a,b,c,d,e,f,g,h}   Benacerraf, Beryl ^{a,b,c,d,e,f,g,h}   Berkowitz, Richard ^{a,b,c,d,e,f,g,h}   Cuckle, Howard ^{a,b,c,d,e,f,g,h}   Depp, Richard ^{a,b,c,d,e,f,g,h}   Goldberg, James ^{a,b,c,d,e,f,g,h}   O'Keeffe, Daniel ^{a,b,c,d,e,f,g,h}   Platt, Lawrence D ^{a,b,c,d,e,f,g,h}   Spitz, Jean Lea ^{a,b,c,d,e,f,g,h}   Toland, Gregory ^{a,b,c,d,e,f,g,h}   Wapner, Ronald ^{a,b,c,d,e,f,g,h}  

^a Department of Medicine   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e Society for Maternal Fetal Medicine   (United States)

^f San Francisco Perinatal Associates   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; ANEUPLOIDY; ARTICLE; CLINICAL RESEARCH; FIRST TRIMESTER PREGNANCY; GENETIC SCREENING; HEALTH CARE ORGANIZATION; HEALTH CARE QUALITY; HUMAN; LEADERSHIP; MEDICAL EDUCATION; MEDICAL SOCIETY; NUCHAL TRANSLUCENCY MEASUREMENT; PHYSICIAN; PRIORITY JOURNAL; PROGRAM EVALUATION; SECOND TRIMESTER PREGNANCY;

EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; QUALITY ASSURANCE, HEALTH CARE;

EID: 84893694597     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000058     Document Type: Article

References (10)

1. Snijders RL, Noble P, Sebire N, Souka A, Nicolaides KH. UK multicenter project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Lancet 1998;352:343-6.
2. Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K, et al; First Trimester Maternal Serum Biochemistry and Fetal Nuchal Translucency Screening (BUN) Study Group. First-trimester screening for trisomies 21 and 18. N Engl J Med 2003;349:1405-13.
3. Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, et al; First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or secondtrimester screening, or both, for Down's syndrome. N Engl JMed 2005;353:2001-11.
4. Available at: http://www.perinatalquality.org. Retrieved November 7, 2013.
5. DM-STAT Inc. Available at: http://www.dmstat.com/. Retrieved December 4, 2012.
6. Nuchal Translucency Quality Review Program. Available at: https://ntqr.org/SM/Provider/wfProviderInformation.aspx#Criteria. Retrieved March 15, 2013.
7. D'Alton ME. Nuchal translucency quality monitoring: the transition from research to clinical care. Obstet Gynecol 2010;116:806-7.
8. Fuchs KM, Spitz JL, Toland G, Bromley B, Benacceraf B, Platt LD, et al. Impact of a required remediation program on nuchal translucency measurements: experience of the Nuchal Translucency Quality Review (NTQR) program. Am J Obstet Gynecol 2012;206:S166.
9. Kagan KO, Etchegaray A, Zhou Y, Wright D, Nicolaides KH. Prospective validation of first-trimester combined screening for trisomy 21. Ultrasound Obstet Gynecol 2009;34: 14-8.
10. Herman A, Maymon R, Dreazen E, Caspi E, Bukovsky I, Weinraub Z. Nuchal translucency audit: a novel image-scoring method. Ultrasound Obstet Gynecol 1998;12:398-403.